Fundraising Fox

Suono Bio

Medford, US · Founded 2016 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

Suono Bio was founded in 2016 by Giovanni Traverso, Robert Langer, and Carl Schoellhammer.

GTGiovanni Traverso
Giovanni Traversoin𝕏Co-FounderInvestor at Teal Bio
RL
Robert LangerCo-founder
CSCarl Schoellhammer
Carl SchoellhammerinCo-founder
AS
Amy SchulmanNamed on SEC filing

Investors · 2

Axil CapitalreportedTokyo
Taiwania CapitalreportedTaipei · $3M – $85M

Reported raises · per SEC filings

Form D private placements

$14M disclosed across 3 rounds · 2017–2023

▶$500KraisedAug 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CARL SCHOELLHAMMERExecutive Officer, Director
  • FREDERICK SHANEDirector
  • GIOVANNI TRAVERSODirector
  • VICTORIA WANGDirector
  • SCOTT KELLOGGExecutive Officer, Director
  • ROBERT LANGERDirector
Offering amount
$3M
Amount sold
$500K
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2MraisedJul 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Carl SchoellhammerExecutive Officer, Director
  • Robert LangerDirector
  • Scott KelloggExecutive Officer, Director
  • Giovanni TraversoDirector
  • Frederick ShaneDirector
Offering amount
$15.2M
Amount sold
$12.2M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJun 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy SchulmanDirector
  • Giovanni TraversoDirector
  • Robert LangerDirector
  • Carl SchoellhammerExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.3M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$263.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Suono Bio has filed a notice of an exempt offering of securities to raise $3,000,000.00 in New Debt Financing. - intelligence360intelligence360.news · Sep 2023Suono Bio rasies $8.5M in oversubscribed Series A - Drug Delivery Businessdrugdeliverybusiness.com · Jul 2021Suono Bio, Inc. Announces Oversubscribed Series A Funding Round Led by Axil Capital and Mizuho Securities Principal Investmentbusinesswire.com · Jul 2021Suono Bio Raises $8.5M in Series A Funding - FinSMEsfinsmes.com · Jul 2021A company that wants to use ultrasounds to deliver drugs just raised money from MIT's new $200 million venture fundfinance.yahoo.com · Sep 2017Suono Bio Raises Seed Funding Round From MIT's the Engine Fund - Business Insiderbusinessinsider.com · Sep 2017

Frequently asked questions

Who founded Suono Bio?
Suono Bio was founded by Giovanni Traverso, Robert Langer, Carl Schoellhammer in 2016.
Who are Suono Bio's investors?
Suono Bio's investors include Axil Capital, Taiwania Capital.
How much funding has Suono Bio raised?
Suono Bio has disclosed $14M raised across 3 rounds.
Where is Suono Bio headquartered?
Suono Bio is headquartered in Medford, US.